Biosimilar Newsletter Archive
-
06.12.25 -- 8 Ways To Drive Resilience In Oncology Drug Supply Chains
6/12/2025
06/12/25 Biosimilar Development Newsletter
-
06.06.25 -- Master The Final Critical Step In Drug Manufacturing
6/6/2025
06/06/25 Biosimilar Development Newsletter
-
06.05.25 -- Lean Thinking For Pharma — Flow Without Facility Upheaval
6/5/2025
06/05/25 Biosimilar Development Newsletter
-
05.29.25 -- ICH Revises Q1 Guideline, Advancing Stability Testing Standards
5/29/2025
05/29/25 Biosimilar Development Newsletter
-
05.22.25 -- A Closer Look At Buffer Recycling For More Sustainable Bioprocessing
5/22/2025
05/22/25 Biosimilar Development Newsletter
-
05.15.25 -- Amgen's Deep Learning Approach To Vial Inspection
5/15/2025
05/15/25 Biosimilar Development Newsletter
-
05.11.25 -- Embracing Outsourcing Quality Management In BioPharm
5/11/2025
05/11/25 Biosimilar Development Newsletter
-
05.08.25 -- Embracing Outsourcing Quality Management In BioPharm
5/8/2025
05/08/25 Biosimilar Development Newsletter
-
05.01.25 -- 3 Strategies For mAb Manufacturing: How Do You Choose?
5/1/2025
05/01/25 Biosimilar Development Newsletter
-
04.24.25 -- Intensifying Downstream Processing With Magnetic Separation
4/24/2025
04/24/25 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more